PIK3C2G fusions
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Dec 29, 2020
Grant Date -
Sep 1, 2016
app pub date -
Jul 30, 2014
filing date -
Jul 30, 2013
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The invention provides to PIK3C2G (phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 gamma) gene fusions and PIK3C2G fusion proteins. The invention further provides methods of diagnosing and treating diseases or disorders associated with PK3C2G fusions, such as conditions mediated by aberrant PIK3C2G expression or activity, or conditions associated with overexpression of PIK.3C2G.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully